Empowering the endometriosis community through knowledge, advocacy, and shared experiences
Promising Development: World's First Ovarian Cancer Vaccine in the Works
Researchers at the University of Oxford are developing the world's first ovarian cancer vaccine, funded by Cancer Research UK. The project, led by Professor Ahmed Ahmed, initially focuses on women with BRCA gene mutations who have a high risk of developing this often-fatal disease. This vaccine could offer an alternative to current invasive preventative surgeries, potentially saving thousands of lives. Unlike existing cancer vaccines, it specifically targets risks associated with BRCA mutations. While promising, the research is still in early stages and will require extensive testing before becoming publicly available.
Aetna Agrees to Settle Lawsuit over Fertility Coverage for LGBTQ+ Customers: What Does This Actually Mean?
Aetna, one of the largest health insurers in the United States, has agreed to settle a lawsuit that accused the company of discriminating against LGBTQ+ customers seeking fertility treatment. The lawsuit, filed in 2021 by Emma Goidel and her spouse, Ilana Caplan, highlighted the disparities in coverage for same-sex couples and heterosexual couples. As part of the settlement, Aetna will make significant changes to its fertility treatment coverage policies, ensuring equal access to artificial insemination and in-vitro fertilization procedures for all customers, regardless of their sexual orientation or gender identity.
